share_log

CVS Health | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Feb 17 05:19
Summary by Futu AI
CVS Health Corporation officer Prem S Shah is set to sell 29,473 shares of common stock on 02/16/2024, with an aggregate market value of $2,267,923.77. The shares to be sold were acquired through various means, including Dividend Reinvestment Plans (DRIP), Employee Stock Purchase Plans, and restricted stock vesting under registered plans, with acquisition dates ranging from 2020 to 2024. The transactions involved both cash payments and services rendered as forms of payment. This planned sale follows a period where no securities were sold in the past three months, as per the latest available data.
CVS Health Corporation officer Prem S Shah is set to sell 29,473 shares of common stock on 02/16/2024, with an aggregate market value of $2,267,923.77. The shares to be sold were acquired through various means, including Dividend Reinvestment Plans (DRIP), Employee Stock Purchase Plans, and restricted stock vesting under registered plans, with acquisition dates ranging from 2020 to 2024. The transactions involved both cash payments and services rendered as forms of payment. This planned sale follows a period where no securities were sold in the past three months, as per the latest available data.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.